Back to News
Market Impact: 0.15

Recross Cardio Announces the 25th Subject Treated in the Global PROTEA-PFO Clinical Program

Source: PR Newswire

Healthcare & BiotechProduct LaunchesTechnology & Innovation

Recross Cardio announced a milestone highlighting growing multicenter experience with its novel PFO Sealing System. The available article text does not specify the milestone, participating centers, or clinical results.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

mildly positive

Sentiment Score

0.20

More News

From AllMind Research

Browse all research